Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children

Background: In 2010, Greenland introduced the 13-valent pneumococcal conjugate vaccine (Prevnar 13®– PCV-13) in the childhood immunisation program. The authors aimed to evaluate the impact of PCV-13 on nasopharyngeal carriage of bacteria frequently associated with respiratory infections in children....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Circumpolar Health
Main Authors: Navne, Johan Emdal, Koch, Anders, Slotved, Hans-Christian, Andersson, Mikael, Melbye, Mads, Ladefoged, Karin, Børresen, Malene
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497538/
https://ncbi.nlm.nih.gov/pubmed/28467237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22423982.2017.1309504
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados